Skip to content

SUCTIONING AT BIRTH WITH BULB SYRINGE OR SUCTION CATHETER: A RANDOMIZED CONTROLLED TRIAL

SUCTIONING AT BIRTH WITH BULB SYRINGE OR SUCTION CATHETER: A RANDOMIZED CONTROLLED TRIAL

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05472155
Acronym
NEOSUC
Enrollment
60
Registered
2022-07-25
Start date
2022-07-21
Completion date
2022-10-30
Last updated
2023-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Resuscitation

Brief summary

This study is designed to compare two different methods of oropharyngeal suctioning (with bulb syringe or suction catheter) in newborn infants at birth.

Detailed description

Objective of the study: This trial aims to compare two different methods of oropharyngeal suctioning (with bulb syringe or suction catheter) in newborn infants needing suctioning at birth. Primary outcome measure: Oxygen saturation during the first 10 minutes of life. Study design: This is a single center, prospective, randomized clinical trial comparing two different methods of oropharyngeal suctioning (with bulb syringe or suction catheter) in newborn infants needing suctioning at birth. Setting: The study is conducted at the St. Luke Catholic Hospital in Wolisso (Ethiopia), which is a level III hospital with around 3,600 deliveries per year. Immediately after birth, all infants needing suctioning are randomized to receive suctioning with bulb syringe or suction catheter. All resuscitative procedures are performed following the Helping Babies Breathe algorithm. An external observer, not involved in the care of the newborn, is responsible of the positioning the probe of the pulse oximeter and the collection of the data. We aim to enroll 60 neonates.

Interventions

DEVICEBulb syringe

Suctioning with a bulb syringe

Suctioned with a suction catheter

Sponsors

Doctors with Africa - CUAMM
CollaboratorOTHER
University Hospital Padova
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Masking is not possible due to the study design. Only statistician who will perform the analysis will be blind to the arm allocation.

Eligibility

Sex/Gender
ALL
Age
1 Minutes to 2 Days
Healthy volunteers
Yes

Inclusion criteria

* inborn infants (and) * need for suctioning at birth (and) * parental consent

Exclusion criteria

* Major congenital malformations * Parental refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Oxygen saturation during the first 10 minutes of life10 minutesPreductal oxygen saturation will be measured by a pulse-oxymeter during the first 10 minutes of life

Secondary

MeasureTime frameDescription
Neonates with heart rate >100 beats per minute at 5 minutes5 minutesNumber (percentage) of neonates with heart rate \>100 bpm at 5 minutes
Episodes of bradycardia in the first 10 minutes of life10 minutesEpisodes of bradycardia will be defined as heart rate \<100 beats per minute in the first 10 minutes of life
Neonates with saturation >80% at 5 minutes5 minutesNumber (percentage) of neonates with saturation \>80% at 5 minutes
Time for achieving transcutaneous saturations >90%30 minutesTime needed for achieving transcutaneous saturations \>90 from birth
Heart rate during the first 10 minutes of life10 minutesHeart rate will be monitored by a pulse-oxymeter during the first 10 minutes of life
Supplemental oxygen in delivery room30 minutesNumber (percentage) of infants who needed supplemental oxygen in delivery room
Admission to the special care unit30 minutesNumber (percentage) of infants who were admitted to the special care unit
Local lesions10 minutesNumber (percentage) of local lesions (defined as bleeding from the mouth and/or the nose) due to suctioning procedure
Respiratory distress during the first 48 hours of life48 hoursNumber (percentage) of infants with respiratory distress (defined as need for supplemental oxygen and/or nasal-CPAP) during the first 48 hours of life
Face-mask ventilation10 minutesNumber (percentage) of infants who need for face-mask ventilation according to the neonatal algorithm

Countries

Ethiopia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026